Vericel (VCEL) Interest & Investment Income (2010 - 2026)
Vericel (VCEL) reported Interest & Investment Income of $1.9 million for Q1 2026, up 11.71% on a YoY basis from $1.7 million in Q1 2025, and down 1.8% sequentially from $1.9 million in Q4 2025.
Vericel (VCEL) Interest & Investment Income (2010 - 2026) Analysis & Trends
Vericel (VCEL) has 17 years of Interest & Investment Income data on file, last reported at $1.9 million in Q1 2026.
- For the quarter ending Q1 2026, Interest & Investment Income rose 11.71% year-over-year to $1.9 million; the trailing twelve-month figure through Mar 2026 stood at $7.2 million (up 14.21% YoY), and the FY2025 full-year result was $7.0 million, up 9.31% from the prior year.
- Interest & Investment Income retreated to $1.9 million in Q1 2026, from $1.9 million in the prior quarter.
- In the past five years, Interest & Investment Income ranged from a high of $1.9 million in Q4 2025 to a low of $88000.0 in Q1 2022.
- A 5-year average of $1.2 million and a median of $1.5 million in 2024 frame the typical range for Interest & Investment Income.
- Across the five-year window, Interest & Investment Income surged 1150.82% in 2022 and dropped 5.96% in 2025, its largest moves.
- Tracing VCEL's Interest & Investment Income over 5 years: stood at $763000.0 in 2022, then jumped by 88.2% to $1.4 million in 2023, then grew by 8.64% to $1.6 million in 2024, then advanced by 20.83% to $1.9 million in 2025, then fell by 1.8% to $1.9 million in 2026.
- Business Quant data shows VCEL's Interest & Investment Income at $1.9 million in Q1 2026, $1.9 million in Q4 2025, and $1.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | Vericel | 2.33 Bn | 2.18 Bn | 49.27 Mn | 1.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.85 Mn |
| Dec 31, 2025 | 1.89 Mn |
| Sep 30, 2025 | 1.81 Mn |
| Jun 30, 2025 | 1.66 Mn |
| Mar 31, 2025 | 1.66 Mn |
| Dec 31, 2024 | 1.56 Mn |
| Sep 30, 2024 | 1.58 Mn |
| Jun 30, 2024 | 1.51 Mn |
| Mar 31, 2024 | 1.76 Mn |
| Dec 31, 2023 | 1.44 Mn |
| Sep 30, 2023 | 1.26 Mn |
| Jun 30, 2023 | 1.10 Mn |
| Mar 31, 2023 | 839,000.00 |
| Dec 31, 2022 | 763,000.00 |
| Sep 30, 2022 | 342,000.00 |
| Jun 30, 2022 | 148,000.00 |
| Mar 31, 2022 | 88,000.00 |
| Dec 31, 2021 | 61,000.00 |
| Sep 30, 2021 | 44,000.00 |
| Jun 30, 2021 | 43,000.00 |